Category: Alzheimer's Disease
South America Alzheimer's Disease
-
Neuroregeneration Therapy Market, By Type of Neuroregeneration Therapy (Stem Cell Therapy, Gene Therapy, Pharmacological Therapy, Neurostimulation Therapy, Others), By Indication (Spinal Cord Injury, Stroke, Traumatic Brain Injury, Parkinson\\\'s Disease, Alzheimer\\\'s Disease, Multiple Sclerosis, Peripheral Nerve Injury, Others), By Mode of Administration (Oral, Injectable, Implantable, Others), By Age Group (Pediatric, Adult, Geriatric), By End User (Hospitals, Specialty Clinics, Research Institutes, Rehabilitation Centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... involves the synthesis of new neurons and connections, providing additional resources to substitute the damaged ones. Neuroregeneration is not just about physical recovery; it's also a vital mechanism for maintaining cognitive functions. It plays a ... Read More
-
Alzheimers disease diagnostics and therapeutics Market, by Product (Therapeutics (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Others) and Diagnostics (Brain Imaging, CSF Test for Alzheimers Disease)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... function independently. Doctors perform a series of tests to rule out other possible causes of impairment. It can be diagnosed in several different ways. Imaging techniques, such as CT and MRI, are primarily used to ... Read More
-
Global Blarcamesine Market, By Route of Adminsitration (Oral, Parenteral), By Application (Alzheimer\\\'s Disease, Parkinson\\\'s Disease , Dementia, Rett Syndrome, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
... sigma-1 receptor forms heterodimers with many other membrane receptors and, as such, influences multiple cellular pathways and physiological processes. Blarcamesine reportedly binds the sigma-1 receptor in the high nanomolar and the muscarinic receptor in the ... Read More
-
Alzheimer's Disease Diagnostics & Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... and Africa) The global Alzheimer’s disease diagnostics and treatment market is poised for significant growth, propelled by technological breakthroughs, increasing awareness initiatives, and the rising prevalence of Alzheimer’s disease globally. With an anticipated compound annual ... Read More
-
Argentina Alzheimer's Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032
... the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Argentina market. Also, factors that are driving and restraining the Alzheimer’s drugs market are highlighted in the study. ... Read More
-
Neurodegenerative Disease Market, By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, and Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, and Other Drug Types), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Neurodegenerative disease is a type of disease in which cells of the central ... Read More
-
Alzheimer's Disease Diagnostics and Therapeutics Market, By Product (Therapeutics [Cholinesterase Inhibitors, NMDA Receptor Antagonists, and Other Therapeutics] and Diagnostics [Brain Imaging and CSF Test for Alzheimer’s Disease]) and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Alzheimer's disease is a neurodegenerative disease that usually starts slowly and progressively worsens. It is a progressive form of ... Read More
-
Latin America Alzheimer’s Disease Therapeutics And Diagnostics Market 2022-2028
... of CAGR over the forecast years from 2022-2028. Mexico, Brazil, and Rest of Latin America are analyzed in the market in this region. In 2019, a major international initiative for Alzheimer’s disease led by the ... Read More
Research Assistance
